8,229 results match your criteria Nephrectomy Radical


Prevalence of frailty syndrome in urological patients undergoing major elective surgical procedure due to malignancy.

Cent European J Urol 2022 15;75(1):52-58. Epub 2022 Feb 15.

Department of Urology and Andrology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

Introduction: The group of elderly urological patients is growing. A majority of urological operations is performed in this group. The current model of preoperative assessment is developed to be effective in younger groups of patients but not in the elderly. Read More

View Article and Full-Text PDF
February 2022

Renal endometriosis: A benign disease with malignant presentation.

Urol Case Rep 2022 Jul 7;43:102110. Epub 2022 May 7.

Shuakat Khanum Memorial Cancer Hospital and Research Center Lahore, Pakistan.

Endometriosis is a common gynecological disorder in which endometrial tissue is located outside the uterine cavity. Urinary tract involvement by endometriosis is uncommon. Renal endometriosis is a rare disorder and is not evident on imaging. Read More

View Article and Full-Text PDF

What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.

Technol Cancer Res Treat 2022 Jan-Dec;21:15330338221095667

569810Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

To assess the prognostic value of preoperative blood-based inflammation biomarkers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR), on the survival outcomes of patients with upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU). We retrospectively studied the data of 172 patients who were diagnosed with UTUC after RNU during 2008 to 2018. We determined the cut-off value by using X-tile software. Read More

View Article and Full-Text PDF

Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report.

J Med Case Rep 2022 May 18;16(1):193. Epub 2022 May 18.

Department of Urology, Nagano Municipal Hospital, 1333-1, Tomitake, Nagano, Nagano, Japan.

Background: Collecting duct carcinoma and sarcomatoid renal cell carcinoma are tumors with poor prognosis. Immune checkpoint inhibitors have been established as the standard treatment for advanced renal cell carcinoma. Some cases of remission of collecting duct carcinoma and sarcomatoid renal cell carcinoma have been reported using immune checkpoint inhibitor interventions. Read More

View Article and Full-Text PDF

A unique case of chromophobe renal cell carcinoma seeding after biopsy.

Urol Case Rep 2022 Jul 13;43:102081. Epub 2022 Apr 13.

Department of Surgery, Urology Division, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5W9, Canada.

We report a unique case for a 1.5 cm Chromophobe Renal Cell Carcinoma (ChRCC) tumor recurrence on the posterior abdominal wall along the renal tumor biopsy tract. This case presented on follow up at 4. Read More

View Article and Full-Text PDF

Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy.

Eur Urol Open Sci 2022 Jun 5;40:112-116. Epub 2022 May 5.

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.

While partial nephrectomy (PN) is generally preferred for localized renal cell carcinoma (RCC), radical nephrectomy (RN) is occasionally required. A new-baseline glomerular filtration rate (NBGFR) >45 ml/min/1.73 m after kidney cancer surgery is associated with strong survival outcomes. Read More

View Article and Full-Text PDF

Clear Cell Renal Cell Carcinoma with Immunotherapy Effect Mimicking Xanthogranulomatous Pyelonephritis.

Int J Surg Pathol 2022 May 16:10668969221101873. Epub 2022 May 16.

2559MetroHealth Medical Center, Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.

Renal cell carcinoma is now increasingly treated with checkpoint inhibitor therapy, predominantly in the metastatic setting or occasionally in the adjuvant setting; however, there is little published histopathology data demonstrating the post-therapy features of renal cell carcinoma tumor tissue. We report a middle-aged man, who was undergoing treatment with pembrolizumab for locally recurrent cutaneous basal cell carcinoma and was incidentally found to have a renal mass. Radical nephrectomy demonstrated a 5. Read More

View Article and Full-Text PDF

Renal Parenchymal Leiomyoma Mimicking Renal Cell Carcinoma: A Case Report.

Curr Med Imaging 2022 May 13. Epub 2022 May 13.

Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

Background: Renal leiomyoma is a challenging diagnostic and therapeutic condition. Given that 90% of leiomyomas originate from the renal capsule, leiomyoma presenting as a renal parenchymal mass is extraordinarily rare.

Case Presentation: Herein, we report the clinical and imaging features of a patient with renal leiomyoma occurring in the renal parenchyma and mimicking renal cell carcinoma. Read More

View Article and Full-Text PDF

Perioperative Outcomes for Radical Nephrectomy and Level III-IV Inferior Vena Cava Tumor Thrombectomy in Patients with Renal Cell Carcinoma.

J Cardiothorac Vasc Anesth 2022 Apr 22. Epub 2022 Apr 22.

Department of Anesthesiology & Perioperative Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN. Electronic address:

Objectives: This study examined the characteristics, intraoperative, and postoperative course of patients undergoing inferior vena cava tumor thrombectomy for metastatic renal cell carcinoma.

Design: A single-center case series that reported demographic data and intraoperative and postoperative outcomes for patients with renal cell carcinoma undergoing inferior vena cava thrombectomy.

Setting: This investigation was performed at a large quaternary referral center. Read More

View Article and Full-Text PDF

Combination of holographic imaging with robotic partial nephrectomy for renal hilar tumor treatment.

Int Urol Nephrol 2022 May 14. Epub 2022 May 14.

Department of Urology, Beijing United Family Hospital and Clinics, JiangTai Road, Chao Yang District, Beijing, 100015, China.

Objectives: To evaluate the clinical value of the holographic imaging technology in combination with robotic-assisted partial nephrectomy (RAPN) for renal hilar tumor treatment.

Patients And Methods: From Dec. 2018 to Dec. Read More

View Article and Full-Text PDF

A preliminary study on the association between epithelial-mesenchymal transition and circulating tumor cells in renal cell carcinoma.

Transl Androl Urol 2022 Apr;11(4):460-471

Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Background: Circulating tumor cells (CTCs) are considered useful prognostic factors for various cancers, and in 2014, our research group conducted a comparative experiment of CTC detection in patients with renal cell cancer (RCC). However, the reason for the low detection rate of CTCs in cancer patients using the CellSearch system is still unknown, although it has been hypothesized to be attributed to the likelihood that CTCs undergoing epithelial-mesenchymal transition (EMT) do not express the CTC biomarkers cytokeratin (CK)8/18/19 or epithelial cell adhesion molecule (EpCAM). The overall aim of the current study was to investigate the expression levels of CK8/18/19 and EpCAM in relation to the EMT biomarkers vimentin and E-cadherin in patients with RCC. Read More

View Article and Full-Text PDF

ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update.

J Am Coll Radiol 2022 05;19(5S):S156-S174

Specialty Chair, University of Alabama at Birmingham, Birmingham, Alabama; and Chair, ACR Appropriateness Committee.

Renal cell carcinoma (RCC) accounts for most malignant renal tumors and is considered the most lethal of all urologic cancers. For follow-up of patients with treated or untreated RCC and those with neoplasms suspected to represent RCC, radiologic imaging is the most valuable component of surveillance, as most relapses and cases of disease progression are identified when patients are asymptomatic. Understanding the strengths and limitations of the various imaging modalities for the detection of disease, recurrence, or progression is essential when planning follow-up regimens. Read More

View Article and Full-Text PDF

Pre-operative Serum Albumin as a Potential Predictor of Benign Lesions in Renal Masses.

Cancer Diagn Progn 2022 May-Jun;2(3):345-350. Epub 2022 May 3.

Department of Urology, Aichi Cancer Center Hospital, Nagoya, Japan.

Background/aim: We investigated pre-operative factors for predicting whether renal masses are benign in order to facilitate the selection of optimal candidates for pre-operative biopsy.

Patients And Methods: We evaluated 278 patients with renal masses suspected to be clinically T1 or T2 renal cell carcinoma. All patients had undergone a partial or radical nephrectomy. Read More

View Article and Full-Text PDF

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.

Eur Urol Open Sci 2022 May 1;39:22-28. Epub 2022 Apr 1.

Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.

Background: T1a renal cell carcinoma (RCC) is typically considered a curable disease, irrespective of the choice of local treatment modality.

Objective: To identify factors associated with the risk of local and distant recurrence, and overall survival (OS) in patients with primary nonmetastatic clinical T1a RCC.

Design Setting And Participants: A population-based nationwide register study of all 1935 patients with cT1a RCC, diagnosed during 2005-2012, identified through The National Swedish Kidney Cancer Register, was conducted. Read More

View Article and Full-Text PDF

Renal cell carcinoma with right atrium tumor thrombus treated with radical nephrectomy and tumor thrombectomy in a patient with previous coronary artery bypass graft: a case report.

Am J Clin Exp Urol 2022 15;10(2):123-128. Epub 2022 Apr 15.

Department of Surgery, University of Miami Miller School of Medicine, Jackson Memorial Hospital Miami, FL, USA.

Renal cell carcinoma (RCC) with inferior vena cava (IVC) and right atrium (RA) tumor thrombus (TT) is a rare occurrence and its resection is surgical challenge. Management becomes even more difficult when the TT causes hepatic vein obstruction and leads to Budd-Chiari syndrome. We report a case of 68-year-old male with right RCC with IVC and RA TT with associated Budd-Chiari syndrome. Read More

View Article and Full-Text PDF

Robotic surgery in comparison to the open and laparoscopic approaches in the field of urology: a systematic review.

J Robot Surg 2022 May 8. Epub 2022 May 8.

Department of Life Sciences, University of Central Punjab, Lahore, Pakistan.

To establish the feasibility of robotic surgical procedures in urology in terms of the applications, merits, and demerits as well as the postoperative and oncological outcomes while comparing it with the conventional approaches. A systematic search of electronic databases was performed to identify Randomized Controlled Trials and Cohort studies on Robot-Assisted urological surgical procedures in comparison with the conventional methods. The quality assessment of included studies was performed using the Newcastle-Ottawa Scale and the revised Cochrane "Risk of Bias" tool. Read More

View Article and Full-Text PDF

Triceps mass - A rare presentation of renal cell carcinoma.

Urol Case Rep 2022 Jul 14;43:102079. Epub 2022 Apr 14.

Urology, Central Adelaide Local Health Network, Australia.

Renal cell carcinoma (RCC) can commonly metastasize to the liver, lungs, bones and brain. We herein report a rare presentation of oligometastatic RCC with isolated synchronous metastasis to the triceps. A 44-year-old male presented with an enlarging mass involving the right triceps. Read More

View Article and Full-Text PDF

Preoperative Embolization of a Delayed Femoral Metastasis of Renal Cell Carcinoma: A Case Report.

Cureus 2022 Apr 3;14(4):e23788. Epub 2022 Apr 3.

Interventional Radiology, Louisiana State University Health Sciences Center, Shreveport, USA.

Preoperative embolization of hypervascular bone metastasis is an effective measure for reducing blood loss during open orthopedic surgery. When the clinician is experienced with the procedure, the risks of the procedure are minimal and final outcomes are typically good. In this study, we report a case of a 50-year-old female patient who presented with a delayed metastatic renal cell tumor in the left proximal femur one year after radical nephrectomy. Read More

View Article and Full-Text PDF

Editorial Comment to Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy: Initial experience in Japan.

IJU Case Rep 2022 May 17;5(3):148. Epub 2022 Feb 17.

Department of Urology School of Medicine Fujita Health University Toyoake Aichi Japan.

View Article and Full-Text PDF

Undifferentiated pleomorphic sarcoma of the retroperitoneum mimicking a cortisol- and catecholamine-secreting adrenal tumor.

IJU Case Rep 2022 May 22;5(3):195-198. Epub 2022 Mar 22.

Department of Urology Toranomon Hospital Tokyo Japan.

Introduction: Retroperitoneal tumors with endocrine abnormalities are suspected to be functional adrenal tumors. Retroperitoneal soft tissue sarcomas are rare tumors, without endocrine potential.

Case Presentation: A 60-year-old male was referred for a 15 cm mass in the left suprarenal space. Read More

View Article and Full-Text PDF

Renal myxoma - a case report of a rare kidney tumor, its differential diagnosis and literature review.

IJU Case Rep 2022 May 23;5(3):207-210. Epub 2022 Mar 23.

Department of Pathology King Faisal Specialist Hospital and Research Center Jeddah Saudi Arabia.

Introduction: Myxoma is a rare benign kidney tumor. Only 18 cases have been described in the literature. We report a new case of renal myxoma that arises from the renal parenchyma. Read More

View Article and Full-Text PDF

Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy: Initial experience in Japan.

IJU Case Rep 2022 May 25;5(3):145-148. Epub 2022 Jan 25.

Department of Urology Hamamatsu University School of Medicine Hamamatsu Japan.

Introduction: Open surgical approach remains the standard treatment for renal cell carcinoma with an inferior vena cava tumor thrombus. In recent years, however, robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy have emerged as minimally invasive alternatives to conventional open surgery.

Case Presentation: Here, we describe a 76-year-old female patient with right renal cell carcinoma with a level I inferior vena cava thrombus undergoing robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy, which was successfully completed with a purely robotic procedure, resulting in the following outcomes: console time,167 min; total operative time, 211 min; and estimated blood loss, 150 mL. Read More

View Article and Full-Text PDF

Multifocal Abdominal Pyomyositis From Subcutaneous Dissemination in an Immunocompetent Patient.

Cureus 2022 Apr 2;14(4):e23766. Epub 2022 Apr 2.

Department of Internal Medicine, Hospital de la Serranía, Ronda, ESP.

A 61-year-old woman presented to the emergency ward complaining of low back pain for a month. She had undergone several spinal surgeries and a right radical nephrectomy 30 years before. A few days earlier she was injected with an intramuscular painkiller in her right buttock. Read More

View Article and Full-Text PDF

SUPRAHEPATIC CAVA THROMBUS DUE TO WILMS TUMOR: TECHNIQUE WITHOUT CARDIOPULMONARY BYPASS.

Urology 2022 Apr 29. Epub 2022 Apr 29.

Registered Nurse, Morton College, Cicero, Illinois, United States.

Wilms tumor is a frequent malignant neoplasia in pediatric population. Extension to the inferior vena cava is a complication that occurs in approximately 4-15% of cases. Surgical techniques derived from the field of adult transplant surgery allow the resection of the tumor with its thrombus extension. Read More

View Article and Full-Text PDF

Is simple nephrectomy the right nomenclature? - Comparing simple and radical nephrectomy to find the answer.

J Family Med Prim Care 2022 Mar 10;11(3):1059-1062. Epub 2022 Mar 10.

Department of Urology, Institute of Nephrourology, Bangalore, Karnataka, India.

Introduction: The word "simple" means "easily done" or "presenting no difficulty." Hence, the "Simple Nephrectomy" (SN) operation should be "easy to perform." However, in clinical practice, we have noticed that SN can be equally or more challenging surgery than radical nephrectomy (RN). Read More

View Article and Full-Text PDF

Percutaneous Large Bore Aspiration Thrombectomy of Tumor Embolism Causing Massive Pulmonary Embolism.

JACC Case Rep 2022 Mar 16;4(6):359-363. Epub 2022 Mar 16.

Division of Vascular and Interventional Radiology, Department of Radiology, Medical University of South Carolina College of Medicine, Charleston, South Carolina, USA.

We used aspiration thrombectomy to treat a 66-year-old man with renal cell carcinoma undergoing radical nephrectomy and caval thrombectomy with a massive pulmonary artery tumor embolism. (). Read More

View Article and Full-Text PDF

Isolated pituitary metastasis of renal cell carcinoma: A case report and systematic review of the literature.

Curr Med Imaging 2022 Apr 26. Epub 2022 Apr 26.

Department of Neurosurgery, Bahçeşehir University School of Medicine, Göztepe Medical Park Training and Education Hospital, Istanbul/ Turkey.

Background- Isolated pituitary gland metastasis is an extremely rare event in renal cell carcinoma. We present a unique case of isolated pituitary metastasis of renal cell carcinoma and a systematic review of literature. Case report - In this case, a screening abdominal ultrasound in an asymptomatic 51-year-old female patient showed a mass in her left kidney. Read More

View Article and Full-Text PDF

Guanylate-binding Protein 2 Expression Is Associated With Poor Survival and Malignancy in Clear-cell Renal Cell Carcinoma.

Anticancer Res 2022 May;42(5):2341-2354

Department of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China;

Background/aim: Clear-cell renal cell carcinoma (ccRCC) is a common recalcitrant cancer. However, little is known about biomarkers of ccRCC. In the present study, we investigated the role of guanylate-binding protein 2 (GBP2), an interferon-induced GTPase, in ccRCC and its potential as a biomarker of this disease. Read More

View Article and Full-Text PDF

Primary Ewing sarcoma of the kidney: A series of four cases.

Authors:
S Patra P Trivedi

Malays J Pathol 2022 Apr;44(1):93-99

The Gujarat Cancer and Research Institute, Department of OncoPathology, New Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat 380016, India.

Introduction: Ewing sarcoma (ES), the neuroectodermal derived tumour typically occurs in the bone and soft tissue of children and young adults. Primary ES of the kidney is strikingly rare and only a few cases and small case series have been documented. Due to the highly aggressive nature of this neoplasm, distinction from other morphological mimickers is truly indispensable in terms of treatment and prognosis. Read More

View Article and Full-Text PDF

Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: A Study of Clinical, Imaging Features and Treatment Outcomes.

Front Oncol 2022 11;12:865263. Epub 2022 Apr 11.

Department of Urology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.

Purpose: To describe the clinical, imaging, pathological features and oncologic outcomes of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney.

Patients And Methods: Twenty-two cases of MTSCC were pathologically identified between January 2004 and April 2021 at our institution. The clinical and imaging findings, pathological features, treatment methods and outcomes of the patients were reviewed. Read More

View Article and Full-Text PDF